(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SEEGENE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

SEEGENE

ST13

US500000088918498

Class

5

Filing

88918498

Registration

6215910

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

15

Latest update

08/05/2026

Trademark type

Combined

Nice classes

5

Filing date

05/15/2020

Registration date

12/08/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/08/2020

Last transaction

08/05/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

03

Owner location

SEOUL, KR

Examiner

KEAM, ALEX S

Law office

M50

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the black word "SEEGENE" to the right of a black circle that contains a red DNA helix. The color white represents transparent areas and is not claimed as a feature of the mark.

Holders and representatives

Holders

SEEGENE INC.

Representatives

Michael T. Smith Birch Stewart Kolasch & Birch, LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Diagnostic test kitskits consisting primarily of diagnostic reagents for medical purposes; diagnostic preparation for medical purposes; diagnostic reagents for medical clinical purposes; diagnostic reagents for medical use; chemical reagents for medical purposes; diagnostic reagents for medical useused for the diagnosis of genetic disease and cancer; diagnostic test kits consisting primarily of diagnostic reagents for medical use used for the diagnosis of genetic disease and cancer; diagnostic kits consisting primarily of diagnostic reagents for the detection of viral infection for medical use; diagnostic kits consisting primarily of diagnostic reagents for the detection of microorganic infection for medical use; diagnostic kits consisting primarily of diagnostic reagents for the detection of symptom arising from viral or microorganic infection for medical use

Publications

History of USPTO decisions and trademark events.

15 publications found

E815

TEAS SECTION 8 & 15 RECEIVED

08/05/2026

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

12/08/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

12/08/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/22/2020

PUBO

PUBLISHED FOR OPPOSITION

09/22/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/02/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/20/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

08/20/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

08/20/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

08/20/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

08/20/2020

DOCK

ASSIGNED TO EXAMINER

08/13/2020

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

06/02/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/30/2020

NWAP

NEW APPLICATION ENTERED

05/19/2020

Continuous trademark protection

Get notified about every new filing that threatens SEEGENE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.